
Akers Biosciences, Inc. Retained Earnings 2011-2026 | AKER
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Akers Biosciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| - | -120 M | -116 M | -103 M | -97.5 M | -94.2 M | -84.9 M | -81.7 M | -79.2 M | -76.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -76.7 M | -120 M | -94.7 M |
Retained Earnings of other stocks in the Medical instruments industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
382 K | - | - | $ 810 M | ||
|
Luminex Corporation
LMNX
|
83.8 M | - | - | $ 1.75 B | ||
|
Alcon
ALC
|
19.4 B | $ 72.81 | -3.44 % | $ 40.4 B | ||
|
The Cooper Companies
COO
|
7.64 B | $ 61.34 | -2.77 % | $ 12.2 B | ||
|
Antares Pharma, Inc.
ATRS
|
-223 M | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
548 M | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
-11.9 M | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
2.13 B | - | -0.05 % | $ 10.3 B | ||
|
Ekso Bionics Holdings
EKSO
|
-262 M | $ 11.44 | 2.05 % | $ 27.8 M | ||
|
Varian Medical Systems, Inc.
VAR
|
1.13 B | - | -0.02 % | $ 16.3 B | ||
|
electroCore
ECOR
|
-191 M | $ 6.15 | - | $ 52.2 K | ||
|
Haemonetics Corporation
HAE
|
352 M | $ 59.01 | -1.39 % | $ 2.97 B | ||
|
ICU Medical
ICUI
|
691 M | $ 115.45 | -4.59 % | $ 2.84 B | ||
|
iRhythm Technologies
IRTC
|
-803 M | $ 120.75 | -3.74 % | $ 3.86 B | ||
|
Isoray
ISR
|
-335 M | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
7.01 B | $ 453.83 | -2.75 % | $ 162 B | ||
|
Glaukos Corporation
GKOS
|
-599 M | $ 116.96 | -2.23 % | $ 5.66 B | ||
|
Repro Med Systems
KRMD
|
-32 M | $ 3.97 | -2.7 % | $ 183 M | ||
|
InfuSystem Holdings
INFU
|
-59.3 M | $ 9.83 | -3.44 % | $ 203 M | ||
|
Masimo Corporation
MASI
|
1.49 B | $ 178.46 | -0.03 % | $ 9.51 B | ||
|
Microbot Medical
MBOT
|
-104 M | $ 2.04 | -2.86 % | $ 93.4 M | ||
|
Milestone Scientific
MLSS
|
-134 M | $ 0.31 | -4.88 % | $ 25.4 M | ||
|
Merit Medical Systems
MMSI
|
824 M | $ 64.84 | -2.85 % | $ 3.84 B | ||
|
Envista Holdings Corporation
NVST
|
-440 M | $ 25.9 | -2.23 % | $ 4.35 B | ||
|
Pulse Biosciences
PLSE
|
-463 M | $ 20.21 | -7.42 % | $ 1.36 B | ||
|
Retractable Technologies
RVP
|
13.9 M | $ 0.62 | -0.46 % | $ 18.6 M | ||
|
STAAR Surgical Company
STAA
|
-148 M | $ 25.48 | -4.57 % | $ 1.26 B | ||
|
Pro-Dex
PDEX
|
35.9 M | $ 49.84 | -3.24 % | $ 164 M | ||
|
STERIS plc
STE
|
2.48 B | $ 212.65 | -3.23 % | $ 21 B | ||
|
LeMaitre Vascular
LMAT
|
185 M | $ 107.27 | -4.57 % | $ 2.43 B | ||
|
Predictive Oncology
POAI
|
-414 M | - | - | $ 31.1 M | ||
|
Teleflex Incorporated
TFX
|
3.15 B | $ 133.3 | -1.64 % | $ 5.95 B | ||
|
BioLife Solutions
BLFS
|
-335 M | $ 19.99 | -4.35 % | $ 921 M | ||
|
Stereotaxis
STXS
|
-583 M | $ 1.82 | -2.15 % | $ 166 M | ||
|
Baxter International
BAX
|
13.7 B | $ 16.9 | -5.8 % | $ 8.67 B | ||
|
ResMed
RMD
|
3.61 B | $ 211.93 | -2.4 % | $ 31 B | ||
|
AtriCure
ATRC
|
-413 M | $ 27.34 | -4.0 % | $ 1.31 B | ||
|
Utah Medical Products
UTMD
|
129 M | $ 65.03 | -2.37 % | $ 211 M | ||
|
Harvard Bioscience
HBIO
|
-215 M | $ 6.13 | -4.96 % | $ 272 M | ||
|
NeuroMetrix
NURO
|
-218 M | - | 5.05 % | $ 9.02 M | ||
|
West Pharmaceutical Services
WST
|
4.37 B | $ 295.36 | 1.18 % | $ 21.4 B | ||
|
DENTSPLY SIRONA
XRAY
|
-1.56 B | $ 11.48 | -2.55 % | $ 2.29 B | ||
|
AngioDynamics
ANGO
|
-429 M | $ 10.66 | -2.91 % | $ 435 M | ||
|
Becton, Dickinson and Company
BDX
|
16.6 B | $ 145.31 | -2.8 % | $ 41.8 B | ||
|
Nephros
NEPH
|
-144 M | $ 3.24 | -2.41 % | $ 33.7 M | ||
|
OraSure Technologies
OSUR
|
-172 M | $ 2.96 | -1.66 % | $ 218 M | ||
|
Repligen Corporation
RGEN
|
433 M | $ 113.11 | -3.68 % | $ 6.3 M |